DDO-2093
DDO-2093 is a potent MLL1-WDR5 protein-protein interaction inhibitor (IC50=8.6 nM; Kd=11.6 nM) with antitumor activity. DDO-2093 selectively inhibits the catalytic activity of MLL complex[1].
Product Specifications
CAS Number
2250024-74-7
UNSPSC
12352005
Target
WDR5
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ddo-2093.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CN(C2=CC=C(N3CCN(C)CC3)C(NC(C4=CC(N)=C(F)C(C)=C4Cl)=O)=C2)N=N1)NCCCN5CCOCC5
Molecular Formula
C29H37ClFN9O3
Molecular Weight
614.11
References & Citations
[1]Chen W, et al. Discovery of a potent MLL1 and WDR5 protein-protein interaction inhibitor with in vivo antitumor activity [published online ahead of print, 2021 Jun 28]. Eur J Med Chem. 2021;223:113677.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RD-S100A8-Ra-01 96 Tests
Rat S100 Calcium Binding Protein A8 (S100A8) ELISA Kit
Sign In for Pricing
View Details RD-S100A8-Ra-02 48 Tests
Rat S100 Calcium Binding Protein A8 (S100A8) ELISA Kit
Sign In for Pricing
View Details 
LA-2401-1 1 mg
Alkaline Phosphatase Conjugated Griffonia simplicifolia Lectin -GS-I-
Sign In for Pricing
View Details 
